Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45RB.
Zhang
Z
Z
Department of Medicine, University of Western Ontario, Canada.
Zhong
R
R
Jiang
J
J
Wang
J
J
Garcia
B
B
Le Feuvre
C
C
White
M
M
Stiller
C
C
Lazarovits
A
A
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D017493:Leukocyte Common Antigens / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D051381:Rats; D011917:Rats, Inbred Lew; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology*; D014184:Transplantation, Homologous / Q000276:immunology
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D017493:Leukocyte Common Antigens